Literature DB >> 21325189

How many "me-too" drugs is too many?

Joshua J Gagne1, Niteesh K Choudhry.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21325189     DOI： 10.1001/jama.2011.152

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  15 in total

1.  Pharmacy and therapeutics committees: leadership opportunities in medication safety for medical toxicologists.

Authors:  Jeanmarie Perrone; Lewis S Nelson
Journal:  J Med Toxicol       Date:  2011-06

2.  Entry time effects and follow-on drug competition.

Authors:  Luiz Flavio Andrade; Catherine Sermet; Sylvain Pichetti
Journal:  Eur J Health Econ       Date:  2014-12-12

3.  Tracking the pharmaceutical pipeline: clinical trials and global disease burden.

Authors:  Marci D Cottingham; Corey A Kalbaugh; Jill A Fisher
Journal:  Clin Transl Sci       Date:  2014-05-09       Impact factor: 4.689

4.  Increasing enrollment in drug trials: the need for greater transparency about the social value of research in recruitment efforts.

Authors:  Mark A Yarborough
Journal:  Mayo Clin Proc       Date:  2013-05       Impact factor: 7.616

5.  The proportion of North American cancer trials that evaluate novel targets.

Authors:  Eli Gumnit; Aden C Feustel; Sandy Wong; Rafia Bosan; Nora Hutchinson; Jonathan Kimmelman
Journal:  Invest New Drugs       Date:  2020-07-18       Impact factor: 3.850

Review 6.  An early indicator of drug success: Top Journal Selectivity Index.

Authors:  Igor Kissin
Journal:  Drug Des Devel Ther       Date:  2013-02-13       Impact factor: 4.162

7.  An Analysis of Follow-On Development in New Drug Classes, January 1986-June 2018.

Authors:  Michael L Lanthier; Kirk W Kerr; Kathleen L Miller
Journal:  Clin Pharmacol Ther       Date:  2019-07-26       Impact factor: 6.903

8.  Genome-guided Investigation of Antibiotic Substances produced by Allosalinactinospora lopnorensis CA15-2(T) from Lop Nor region, China.

Authors:  Chen Huang; Ross Ka-Kit Leung; Min Guo; Li Tuo; Lin Guo; Wing Wai Yew; Inchio Lou; Simon Ming Yuen Lee; Chenghang Sun
Journal:  Sci Rep       Date:  2016-02-11       Impact factor: 4.379

9.  Challenging research on human subjects: justice and uncompensated harms.

Authors:  Stephen Napier
Journal:  Theor Med Bioeth       Date:  2013-02

Review 10.  Can formulation and drug delivery reduce attrition during drug discovery and development-review of feasibility, benefits and challenges.

Authors:  S Basavaraj; Guru V Betageri
Journal:  Acta Pharm Sin B       Date:  2014-01-24       Impact factor: 11.413
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.